Research shows the cell clusters improve heart function because they have much better retention rates compared to single cell injections—the clusters persisted inside the heart walls of mice models for as long as five months after transplantation, a significant advancement.
“At 20 weeks we were still able to see the cells,” Monsanto [a SDSU researcher] said. “Our design takes advantage of the inherent beneficial attributes of three distinct cardiac cell types, each known to possess beneficial properties that blunt heart disease in their own unique way.”
